Domenica Lorusso
Università Cattolica del Sacro Cuore(IT)University of Foggia(IT)Gynecologic Oncology Group(US)Humanitas University(IT)University of Milan(IT)Agostino Gemelli University Polyclinic(IT)MultiMedica(IT)Ospedale A. Perrino(IT)Associazione Italiana Di Oncologia Medica(IT)Ministry of Infrastructures and Transport(IT)Humanitas (United States)(US)University of the Sacred Heart(JP)Fondazione Humanitas per la Ricerca(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)Fondazione IRCCS Istituto Nazionale dei Tumori(IT)IRCCS Humanitas Research Hospital(IT)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer(2016)2,417 cited
- → Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer(2019)2,180 cited
- → Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer(2019)1,962 cited
- → ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma(2020)1,861 cited
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up(2015)1,359 cited